All results
2 results for randomized phase iii double blinded placebo controlled trial aspirin adjuvant therapy
-
TN-31 JAKPOT T1D
A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…
- Ages
- 12 Years - 35 Years
- Sexes
- All
-
BLOCK-SAH
BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of…
- Ages
- 18 Years - 85 Years
- Sexes
- All